Don't Let the "No" Win: Your 5 Step Guide to Overturning Rheumatology Drug Denials
Getting a denial for a high-cost rheumatology drug (like a biologic) is frustrating, but it's often reversible. Insurance companies deny a significant share of prior authorization (PA) requests, yet studies show over 80% of these initial rejections are overturned on appeal. This guide provides an accessible, step-by-step action